BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10980270)

  • 21. Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain.
    Besson A; Haddjeri N; Blier P; de Montigny C
    Eur Neuropsychopharmacol; 2000 May; 10(3):177-88. PubMed ID: 10793320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus.
    Sprouse J; Braselton J; Reynolds L
    Biol Psychiatry; 2000 Jun; 47(12):1050-5. PubMed ID: 10862804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies.
    Sprouse J; Braselton J; Reynolds L; Clarke T; Rollema H
    Synapse; 2001 Jul; 41(1):49-57. PubMed ID: 11354013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of standardized extracts of St. John's wort on the single-unit activity of serotonergic dorsal Raphe neurons in awake cats: comparisons with fluoxetine and sertraline.
    Fornal CA; Metzler CW; Mirescu C; Stein SK; Jacobs BL
    Neuropsychopharmacology; 2001 Dec; 25(6):858-70. PubMed ID: 11750179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine's antidepressant-like profile on the differential reinforcement of low rates 72-s schedule in rats.
    Cousins MS; Seiden LS
    Psychopharmacology (Berl); 2000 Mar; 148(4):438-42. PubMed ID: 10928318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 5-HT1A receptor antagonist p-MPPI blocks 5-HT1A autoreceptors and increases dorsal raphe unit activity in awake cats.
    Bjorvatn B; Fornal CA; Martín FJ; Metzler CW; Jacobs BL
    Eur J Pharmacol; 1998 Sep; 356(2-3):167-78. PubMed ID: 9774246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pindolol increases extracellular 5-HT while inhibiting serotonergic neuronal activity.
    Fornal CA; Martín FJ; Mendlin A; Metzler CW; Bjorvatn B; Jacobs BL
    Eur J Pharmacol; 1999 Jul; 377(2-3):187-91. PubMed ID: 10456429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT.
    Bonnefont J; Chapuy E; Clottes E; Alloui A; Eschalier A
    Pain; 2005 Apr; 114(3):482-490. PubMed ID: 15777873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the putative 5-hydroxytryptamine1A antagonists BMY 7378, NAN 190 and (-)-propranolol on serotonergic dorsal raphe unit activity in behaving cats.
    Fornal CA; Marrosu F; Metzler CW; Tada K; Jacobs BL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1359-66. PubMed ID: 7932190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological evidence for the tonic activation of 5-HT(1A) autoreceptors in the rat dorsal raphe nucleus.
    Haddjeri N; Lavoie N; Blier P
    Neuropsychopharmacology; 2004 Oct; 29(10):1800-6. PubMed ID: 15127086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice.
    Evrard A; Laporte AM; Chastanet M; Hen R; Hamon M; Adrien J
    Eur J Neurosci; 1999 Nov; 11(11):3823-31. PubMed ID: 10583471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats.
    Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction studies of 5-HT1A receptor antagonists and selective 5-HT reuptake inhibitors in isolated aggressive mice.
    Sànchez C
    Eur J Pharmacol; 1997 Sep; 334(2-3):127-32. PubMed ID: 9369340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
    Romero L; Artigas F
    J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do 5-HT1B/1D autoreceptors modulate dorsal raphe cell firing? In vivo electrophysiological studies in guinea pigs with GR127935.
    Sprouse J; Reynolds L; Rollema H
    Neuropharmacology; 1997; 36(4-5):559-67. PubMed ID: 9225281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse.
    Knobelman DA; Hen R; Lucki I
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1083-91. PubMed ID: 11504805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA; Hen R; Blendy JA; Lucki I
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of co-administration of a monoamine oxidase inhibitor and a 5-HT1A receptor antagonist on 5-hydroxytryptamine cell firing and release.
    Sharp T; Gartside SE; Umbers V
    Eur J Pharmacol; 1997 Feb; 320(1):15-9. PubMed ID: 9049597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.